272 related articles for article (PubMed ID: 24513574)
1. Deregulation of an imprinted gene network in prostate cancer.
Ribarska T; Goering W; Droop J; Bastian KM; Ingenwerth M; Schulz WA
Epigenetics; 2014 May; 9(5):704-17. PubMed ID: 24513574
[TBL] [Abstract][Full Text] [Related]
2. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
3. Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.
Ribarska T; Bastian KM; Koch A; Schulz WA
Asian J Androl; 2012 May; 14(3):436-50. PubMed ID: 22367183
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.
Iglesias-Platas I; Martin-Trujillo A; Petazzi P; Guillaumet-Adkins A; Esteller M; Monk D
Hum Mol Genet; 2014 Dec; 23(23):6275-85. PubMed ID: 24993786
[TBL] [Abstract][Full Text] [Related]
5. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
6. Altered DNA methylation and expression of PLAGL1 in cord blood from assisted reproductive technology pregnancies compared with natural conceptions.
Vincent RN; Gooding LD; Louie K; Chan Wong E; Ma S
Fertil Steril; 2016 Sep; 106(3):739-748.e3. PubMed ID: 27178226
[TBL] [Abstract][Full Text] [Related]
7. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
8. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring.
Vidal AC; Murphy SK; Murtha AP; Schildkraut JM; Soubry A; Huang Z; Neelon SE; Fuemmeler B; Iversen E; Wang F; Kurtzberg J; Jirtle RL; Hoyo C
Int J Obes (Lond); 2013 Jul; 37(7):907-13. PubMed ID: 23609933
[TBL] [Abstract][Full Text] [Related]
9. Expression of KCNQ1OT1, CDKN1C, H19, and PLAGL1 and the methylation patterns at the KvDMR1 and H19/IGF2 imprinting control regions is conserved between human and bovine.
Robbins KM; Chen Z; Wells KD; Rivera RM
J Biomed Sci; 2012 Nov; 19(1):95. PubMed ID: 23153226
[TBL] [Abstract][Full Text] [Related]
10. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
11. Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer.
Kron K; Trudel D; Pethe V; Briollais L; Fleshner N; van der Kwast T; Bapat B
Clin Cancer Res; 2013 Jul; 19(13):3450-61. PubMed ID: 23549870
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
13. Newborns of obese parents have altered DNA methylation patterns at imprinted genes.
Soubry A; Murphy SK; Wang F; Huang Z; Vidal AC; Fuemmeler BF; Kurtzberg J; Murtha A; Jirtle RL; Schildkraut JM; Hoyo C
Int J Obes (Lond); 2015 Apr; 39(4):650-7. PubMed ID: 24158121
[TBL] [Abstract][Full Text] [Related]
14. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
15. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions.
Nelissen EC; Dumoulin JC; Daunay A; Evers JL; Tost J; van Montfoort AP
Hum Reprod; 2013 Apr; 28(4):1117-26. PubMed ID: 23343754
[TBL] [Abstract][Full Text] [Related]
16. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
17. Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
Vinarskaja A; Schulz WA; Ingenwerth M; Hader C; Arsov C
Urol Oncol; 2013 Jul; 31(5):622-7. PubMed ID: 21803613
[TBL] [Abstract][Full Text] [Related]
18. Differentially methylated regions of imprinted genes in prenatal, perinatal and postnatal human tissues.
Murphy SK; Huang Z; Hoyo C
PLoS One; 2012; 7(7):e40924. PubMed ID: 22808284
[TBL] [Abstract][Full Text] [Related]
19. EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Zoma M; Curti L; Shinde D; Albino D; Mitra A; Sgrignani J; Mapelli SN; Sandrini G; Civenni G; Merulla J; Chiorino G; Kunderfranco P; Cacciatore A; Kokanovic A; Rinaldi A; Cavalli A; Catapano CV; Carbone GM
Nat Commun; 2021 Jul; 12(1):4147. PubMed ID: 34230470
[TBL] [Abstract][Full Text] [Related]
20. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
